Early Type 2 Diabetes Achieves Remission With Intensive Outpatient Pharmacotherapy: RCT Written By Aashi verma3 Sept 2026 7:00 AM ISTA recent randomized control trial published in the Indian Journal of Endocrinology and Metabolism in April 2025 demonstrates that early Type 2...
State Drug Alert: CDSCO Flags 199 Samples Including Paracetamol, Pantoprazole, Cefixime as Not of Standard Quality Written By Susmita Roy24 Aug 2026 2:30 PM ISTNew Delhi: Continuing its nationwide surveillance of drug quality, the Central Drugs Standard Control Organisation (CDSCO) has flagged 199 drug,...
NPPA Fixes Retail Prices for 39 New Drug Formulations Including Tenecteplase at Rs 60,238 Written By Farhat Nasim10 July 2026 2:28 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the provisions of the...
State Drug Alert: 111 Batches Including Paracetamol, Telmisartan Fail CDSCO Quality Tests Written By Susmita Roy25 Jun 2026 8:15 PM ISTNew Delhi: Continuing its nationwide surveillance of drug quality, the Central Drugs Standard Control Organisation (CDSCO) has flagged 111 drug,...
NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details Written By Susmita Roy28 March 2026 8:02 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
Expert Panel Flags Gaps in Mascot Health's Diabetes FDC Trial, Seeks Revised Phase IV Protocol Written By Parthika Patel27 March 2026 11:12 PM ISTNew Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended...
CDSCO Panel Recommends Key Changes in Phase III Study of Glimepiride-Linagliptin FDC Written By Susmita Roy22 March 2026 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report for Glimepiride 1 mg/2 mg plus Linagliptin 5 mg/5 mg Tablets, the Subject Expert...
SC Seeks Centre, DCGI Response on Micro Labs' Plea Against Anti-Diabetic FDC Ban Written By Susmita Roy26 Feb 2026 10:26 PM ISTNew Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro...
Delhi High Court Restores Ban on Triple-Drug Diabetes Pills, Flags Safety Risks Written By Susmita Roy16 Jan 2026 10:50 AM ISTNew Delhi: The Delhi High Court in January 2026 restored the Centre's ban on certain triple-drug fixed dose combinations (FDCs) used in the treatment...
CDSCO Alert: 64 Drug Batches Including Metformin, Paracetamol Declared Not of Standard Quality in November Written By Susmita Roy20 Dec 2025 6:36 PM ISTNew Delhi: In a strong reminder of persistent quality concerns in India's pharmaceutical supply chain, 64 batches of drugs and medical products have...
Kerala Blocks 17 Faulty Medicines Including Rabeprazole, Ciprofloxacin After Counterfeit Seizure Written By Parthika Patel10 Dec 2025 9:20 PM ISTThiruvananthapuram: In a major regulatory move aimed at strengthening drug safety, the Kerala government has banned the sale of 10 allopathic...
A Hidden Epidemic: Addressing Visceral Fat and Insulin Resistance in Non-Obese T2DM with Pioglitazone-Based Therapies Written By Dr. K M Suryanarayana VSM5 Nov 2025 11:15 AM ISTMetabolically unhealthy non-obese individuals (MUNO) comprise around 20% of the normal-weight population and have a 3.14-fold higher risk of...
